Aberrant activation of Wnt/β-
catenin signaling, resulting in the expression of Wnt-regulated oncogenes, is recognized as a critical factor in the etiology of
colorectal cancer. Occupancy of β-
catenin at promoters of Wnt target genes drives transcription, but the mechanism of β-
catenin action remains poorly understood. Here, we show that
CARM1 (
coactivator-associated arginine methyltransferase 1) interacts with β-
catenin and positively modulates β-
catenin-mediated gene expression. In
colorectal cancer cells with constitutively high Wnt/β-
catenin activity, depletion of
CARM1 inhibits expression of endogenous Wnt/β-
catenin target genes and suppresses clonal survival and anchorage-independent growth. We also identified a
colorectal cancer cell line (RKO) with a low basal level of β-
catenin, which is dramatically elevated by treatment with Wnt3a. Wnt3a also increased the expression of a subset of endogenous Wnt target genes, and
CARM1 was required for the Wnt-induced expression of these target genes and the accompanying dimethylation of
arginine 17 of
histone H3. Depletion of β-
catenin from RKO cells diminished the Wnt-induced occupancy of
CARM1 on a Wnt target gene, indicating that
CARM1 is recruited to Wnt target genes through its interaction with β-
catenin and contributes to transcriptional activation by mediating events (including
histone H3 methylation) that are downstream from the actions of β-
catenin. Therefore,
CARM1 is an important positive modulator of Wnt/β-
catenin transcription and neoplastic transformation, and may thereby represent a novel target for therapeutic intervention in
cancers involving aberrantly activated Wnt/β-
catenin signaling.